The upheaval of political balances following the November vote in the US has the potential to radically change the economic scenario, with a mix of structural reforms and other measures (tax system, healthcare, spending on infrastructure and defence, protectionism, immigration, deregulation)…..
Sign up for our free newsletter to receive weekly news from BONDWorld. Click here to register for your free copy
Intesa Sanpaolo – Research Department For professional investors and advisers only
However, the broad scope of the administration’s agenda is still extremely uncertain as for details and timing, also because it requires coordination with Congress on a number of issues. Therefore, our baseline scenario for 2017 is largely unchanged compared to December: we forecast growth at 2.1% in 2017, 2.5% in 2018, and 2.3% in 2019, and a return to potential growth as of 2020. Our scenario is based on two assumptions: 1) the tax reform will not be approved before 2017Q4, and will reap economic effects starting in mid2018; 2) the net effects of the new measures should be moderately expansionary (+0.4-0.5pp over two years), with likely major redistribution among business sectors and households, and possible downside risks (protectionism, regressive fiscal policy, slower labour force).
The Administration’s agenda covers several themes:
1) health care,
3) discretionary spending (stronger spending on infrastructures and defence, lower on other items),
6) delocalisation and international trade.
The first three themes require coordination with Congress for legislation, and will probably result in measures with moderately expansionary net effects on growth. The other three, on which the President has a free hand, have potentially negative implications for both domestic and global growth, in light of the administration’s strong protectionist bias: the risk of trade wars and of growth being held back by slower labour force growth should not be underestimated.
The health care reform is the first major item on the legislative agenda. The debate on the American Health Care Act (AHCA) has laid bare the deep differences within the Republican party, split between conservatives in the House and centrists in the Senate. At the time of our writing, the House vote is still uncertain and, even if positive, will ratify a compromise unsatisfactory for all sides, partly achieved thanks to Trump’s active involvement. Moreover, passage at the House does not guarantee a favourable vote at the Senate. Finally, the President’s standing is fragile, in light of the decline of his approval rate, which has deepened after confirmation of the investigation on the ties between the Trump campaign and the Russian government. Whatever the outcome of the healthcare vote, the AHCA path indicates how hard it will be to move on the next reforms, equally relevant for the electorate and even more so for the markets, such as the tax reform and infrastructure spending.
The main focus will be on the tax reform. The starting point is the Ryan plan, which includes:
a) for businesses, changing the taxable base from earnings to cash flow, with territorial correction (excluding imports and exports), tax rate cuts, a widening of the taxable base, repatriation of earnings, and immediate investment expending;
b) for households, fewer and lower tax rates on personal income and capital gains, abolition of estate and gift taxes, and smaller deductions.
The forecast impact over 10 years on the cumulated deficit is an increase of 2.4 trillion dollars (static estimate) and between 0 and around 400 billion dollars (dynamic estimate). It will be hard to reach an agreement in Congress, given the major redistribution effects between industrial sectors and household income brackets. The territorial correction factor is crucial, as it is estimated to generate revenues of around 1.1 trillion over 10 years, in part “financing” other aspects of the reform, as well as encouraging the relocation of production and quenching the multinationals’ tax avoidance. At the present stage, it is hard to predict which elements of the Ryan plan will survive negotiations, although the approaching of the midterm elections in 2018 means there will be a strong chance of an agreement being reached on the reform by early 2018. In our view, the combination of measures included in the reform will result in major redistribution effects, likely much larger than the net expansionary effects, and in moderate positive support to growth in 2018-19. However, many months of battling among Republicans lie ahead, and will require a credible President: therefore, the process promises to be far from smooth
The financial analysts who prepared this report, and whose names and roles appear on the first page, certify that: (1) The views expressed on companies mentioned herein accurately reflect independent, fair and balanced personal views; (2) No direct or indirect compensation has been or will be received in exchange for any views expressed. Specific disclosures: The analysts who prepared this report do not receive bonuses, salaries, or any other form of compensation that is based upon specific investment banking transactions.
This research has been prepared by Intesa Sanpaolo S.p.A. and distributed by Banca IMI S.p.A. Milan, Banca IMI SpA-London Branch (a member of the London Stock Exchange) and Banca IMI Securities Corp (a member of the NYSE and NASD). Intesa Sanpaolo S.p.A. accepts full responsibility for the contents of this report. Please also note that Intesa Sanpaolo S.p.A. reserves the right to issue this document to its own clients. Banca IMI S.p.A. and Intesa Sanpaolo S.p.A. are both part of the Gruppo Intesa Sanpaolo. Intesa Sanpaolo S.p.A. and Banca IMI S.p.A. are both authorised by the Banca d’Italia, are both regulated by the Financial Services Authority in the conduct of designated investment business in the UK and by the SEC for the conduct of US business.
Opinions and estimates in this research are as at the date of this material and are subject to change without notice to the recipient. Information and opinions have been obtained from sources believed to be reliable, but no representation or warranty is made as to their accuracy or correctness. Past performance is not a guarantee of future results. The investments and strategies discussed in this research may not be suitable for all investors. If you are in any doubt you should consult your investment advisor.
This report has been prepared solely for information purposes and is not intended as an offer or solicitation with respect to the purchase or sale of any financial products. It should not be regarded as a substitute for the exercise of the recipient’s own judgement.
No Intesa Sanpaolo S.p.A. or Banca IMI S.p.A. entities accept any liability whatsoever for any direct, consequential or indirect loss arising from any use of material contained in this report.
This document may only be reproduced or published together with the name of Intesa Sanpaolo S.p.A. and Banca IMI S.p.A.. Intesa Sanpaolo S.p.A. and Banca IMI S.p.A. have in place a Joint Conflicts Management Policy for managing effectively the conflicts of interest which might affect the impartiality of all investment research which is held out, or where it is reasonable for the user to rely on the research, as being an impartial assessment of the value or prospects of its subject matter. A copy of this Policy is available to the recipient of this research upon making a written request to the Compliance Officer, Intesa Sanpaolo S.p.A., 90 Queen Street, London EC4N 1SA.
Intesa Sanpaolo S.p.A. has formalised a set of principles and procedures for dealing with conflicts of interest (“Research Policy”). The Research Policy is clearly explained in the relevant section of Banca IMI’s web site (www.bancaimi.com).
Member companies of the Intesa Sanpaolo Group, or their directors and/or representatives and/or employees and/or members of their households, may have a long or short position in any securities mentioned at any time, and may make a purchase and/or sale, or offer to make a purchase and/or sale, of any of the securities from time to time in the open market or otherwise. Intesa Sanpaolo S.p.A. issues and circulates research to Qualified Institutional Investors in the USA only through Banca IMI Securities Corp., 245 Park Avenue, 35th floor, 10167 New York, NY,USA, Tel: (1) 212 326 1230. Residents in Italy: This document is intended for distribution only to professional investors as defined in art.31, Consob Regulation no. 11522 of 1.07.1998 either as a printed document and/or in electronic form. Person and residents in the UK: This document is not for distribution in the United Kingdom to persons who would be defined as private customers under rules of the FSA.
US persons: This document is intended for distribution in the United States only to Qualified Institutional Investors as defined in Rule 144a of the Securities Act of 1933. US Customers wishing to effect a transaction should do so only by contacting a representative at Banca IMI Securities Corp. in the US (see contact details above).
Trading Ideas are based on the market’s expectations, investors’ positioning and technical, quantitative or qualitative aspects. They take into account the key macro and market events and to what extent they have already been discounted in yields and/or market spreads. They are also based on events which are expected to affect the market trend in terms of yields and/or spreads in the short-medium term. The Trading Ideas may refer to both cash and derivative instruments and indicate a precise target or yield range or a yield spread between different market curves or different maturities on the same curve. The relative valuations may be in terms of yield, asset swap spreads or benchmark spreads.
Coverage Policy And Frequency Of Research Reports
Intesa Sanpaolo S.p.A. trading ideas are made in both a very short time horizon (the current day or subsequent days) or in a horizon ranging from one week to three months, in conjunction with any exceptional event that affects the issuer’s operations. In the case of a short note, we advise investors to refer to the most recent report published by Intesa Sanpaolo S.p.A’s Research Department for a full analysis of valuation methodology, earnings assumptions and risks. Research is available on IMI’s web site (www.bancaimi.com) or by contacting your sales representative.